VivoSim Labs, Inc. (the "Company" or "VivoSim") announced today that its NAMkindtm platform for intestinal efficacy prediction was recognized with a blue ribbon "Poster of Distinction" award at the ...

Dr. Lindsay Hannan discusses findings that showed use of advanced medical therapy in ulcerative colitis have not improved ...

In this interview, Dr Ryan Stidham discusses the various ways in which artificial intelligence is being used to streamline ...

Intestinal ultrasound (IUS) and magnetic resonance imaging (MRI) were effective imaging modalities for the assessment of the ...

This study compared the efficacy of budesonide MMX with placebo in patients with active, mild-to-moderate ulcerative colitis (UC). Design Patients were randomised 1:1:1:1 to receive budesonide MMX 9 ...